Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression

Polish Journal of Pharmacology

Volumn 48, Issue 5, 1996, Pages 503-506

  Kubera, Marta ^a   Symbirtsev, Andrey ^b   Basta Kaim, Agnieszka ^a   Borycz, Jolanta ^a   Roman, Adam ^a   Papp, Mariusz ^a   Claesson, Mogens ^c  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b Res Inst of Highly Pure Bioprep   (Russian Federation)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

chronic; imipramine; interleukins; splenocytes; stress model of depression

Indexed keywords

ANTIDEPRESSANT AGENT; CONCANAVALIN A; IMIPRAMINE; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; SUCROSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; RAT; SPLEEN CELL; STRESS;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CELL DIVISION; CHRONIC DISEASE; CONCANAVALIN A; DEPRESSION; IMIPRAMINE; INTERLEUKIN-1; INTERLEUKIN-2; INTERLEUKIN-6; MALE; MITOGENS; RATS; RATS, WISTAR; SPLEEN; STRESS, PSYCHOLOGICAL;

EID: 0030449407     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Albrecht J., Helderman J. H., Schlesser M. A., Rush A. J.: A controlled study of cellular immune function in active disorders before and during somatic therapy. Psychiat. Res., 1985, 15, 185-193.
2. Andreoli A. V., Keller S. E., Rabaeus M., Marin P., Bartlett J. A., Taban C.: Depression and immunity: age, severity, and clinical course. Brain Behav. Immun., 1993, 7, 279-292.
3. Devoino L., Alperina E., Idova G.: Dopaminergic stimulation of the immune reaction: interaction of serotoninergic and dopaminergic systems in neuroimmunomodulation. Int. J. Neurosci., 1988, 40, 271-288.
4. Devoino L., Morovova N., Cheido M.: Participation of serotoninergic system in neuroimmunomodulation: intraimmune mechanisms and pathways providing an inhibitory effect. Int. J. Neurosci., 1988, 40, 111-128.
5. Holan V., Minowada J.: Enhancement of interleukin-2 (IL-2) production by 6 different cytokines: heterogenity among IL-2 producing T cell clones. Folia Biol. Prague, 1993, 39, 1-13.
6. Kent S., Bluthe R.-M., Kelley K. W., Dantzer R.: Sickness behavior as a new target for drug development. Trends Pharmacol. Sci., 1992, 13, 24-28.
7. Kubera M, Basta-Kaim A., Papp M.: The effect of chronic treatment with imipramine on the immunoreactivity of animals subjected to a chronic mild stress model of depression. Immunopharmacology, 1995, 30, 225-230.
8. Maes M., Bosmans E., Suy E., Vandervorst C., Dejonckheere C., Minner B., Raus J.: Depression-related disturbance in mitogen-induced lymphocyte responses, interleukin-1β, and soluble interleukin-2-receptor production. Acta Psychiat. Scand., 1991, 84, 379-386.
9. Maes M., Lambrechts L, Bosmans E., Jacobs J., Suy E., Vandervorst C., De Jonckheere C., Minner B., Raus J.: Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol. Med., 1992, 22, 45-53.
10. Maes M., Smith R., Scharpe S.: The monocyte-T-lymphocyte hypothesis of major depression. Psychoneoroendocrinology, 1995, 20, 111-116.
11. Rabin B. S., Cohen S., Ganguli R., Lysle D. T., Cunnick J. E.: Bidirectional interaction between the central nervous system and the immune system. Crit. Rev. Immun., 1989, 9, 279-310.
12. Rossenwasser L. J., Diharello C. A.: Ability of human leukocytic pyrogen to enhance phytohemagglutinin induced murine thymocyte proliferation. Cell. Immunol., 1981, 63, 134-142.
13. Sluzewska A., Rybakowski J. K., Sobieska M., Wiktorowicz K.: Concentration and microheterogeneity of alpha-1-acid glycoprotein and alpha-1-antichymotrypsin in depressed patients during fluoxetine treatment. Pol. J. Pharmacol., 1994, 46, 241-242.
14. Willner P.: Animal models of depression: an overview. Pharmacol. Ther., 1990, 45, 425-455.
15. Willner P., Golembiowska K., Klimek V., Muscat R.: Changes in mesolimbic dopamine may explain stress-induced anhedonia. Psychobiology, 1991, 1, 79-84.
16. Wodarz N., Rupprecht R., Kornhuber J., Schmitz B., Wild K., Riederer P.: Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder. J. Affect Disorders, 1992, 25, 31-38.